TRADEMARK APPLICATION NO. 77278969 - CLOSURE - T1093US
`
`Page 1 of4
`
`T0.'
`
`Subject:
`
`Sent:
`
`Sent As:
`
`Attachments:
`
`Medtronic, Inc. (tr_ade_mark@m§(_1t_ron_ic.coZm)
`
`TRADEMARK APPLICATION NO. 77278969 - CLOSURE - T1093US
`
`2/19/2009 5:39:41 PM
`
`ECOM114@USPTO.GOV
`
`Atta9hm<:I1,t;.1
`Attachment — 2
`
`Attachment - 3
`
`Atta,chr,n9nL-A
`Attachment - 5
`
`Attachment - 6
`
`Attaghmgnt,-J
`Attachment - 8
`
`Attachment - 9
`
`Attachment - 10
`
`Attachment - 11
`
`Attachment - 12
`
`Attachment ~ 13
`
`Attachment - 14
`
`Attachment - 15
`
`Attachment - 16
`
`Attachment - 17
`
`Attachment - 18
`
`Attachment - 19
`
`Attachment - 20
`
`Attachment — 21
`
`Attachment — 22
`
`Attachment - 23
`
`Attachment - 24
`
`Attachment ~ 25
`
`Attachment - 26
`
`Attachment - 27
`
`Attachment - 28
`
`Attachment - 29
`
`Attachment - 30
`
`Attachment - 31
`
`Attachment - 32
`
`Attachment - 33
`
`Attachment - 34
`
`Attachment - 35
`
`Attachment — 36
`
`Attachment — 37
`
`Attachment - 38
`
`file://\\ticrs-ais-O1\ticrsexport\HtmlToTifiInput\REC00012009_03_O4_1 1_02_10_T1‘AB08...
`
`3/4/2009
`
`

`
`TRADEMARK ‘APPLICATION NO. 77278969~- CLOSURE — T1093US
`
`Page 2 of 4
`
`Afiaghment - 39
`Attachment — 40
`
`Attachment - 41
`
`Aiaghmcntt -32
`Attachment - 43
`
`Attachment - 44
`
`Afiaghmcnt ;4,5
`Attachment - 46
`
`Attachment - 47
`
`Att,ac,hrnent — 48,
`Attachment - 49
`
`Attachment - 50
`
`Attaghrntcnt - 51
`Attachment - 52
`
`Attachment - 53
`
`Attachment - 54
`
`Attachment - 55
`
`Attachment - 56
`
`Attachment - 57
`
`Attachment - 58
`
`Attachment - 59
`
`Attachment - 60
`
`Attachment - 61
`
`Attachment - 62
`
`Attachment - 63
`
`Attachment - 64
`
`Attachment - 65
`
`Attachment — 66
`
`Attachment - 67
`
`Attachment - 68
`
`Attachment - 69
`
`Attachment - 70
`
`Attachment - 71
`Attachment — 72
`
`Attachment - 73
`
`Attachment - 74
`
`Attachment - 75
`
`Attachment - 76
`
`Attachment - 77
`
`Attachment - 78
`Attachment - 79
`
`Attachment - 80
`Attachment - 81
`
`Attachment — 82
`
`.
`
`~
`
`i
`
`»
`
`x
`\
`
`7
`
`file://\\ticrs—ais-O1\.ticrsexp0rt\HtmlT0Tif‘flnput\REC000 12009_03_04_1 1_02_10_TTAB08...
`
`3/4/2009
`
`

`
`TRADEMARK APPLICATION NO. 77278969 - CLOSURE - T1093US
`
`Page 3 of 4
`
`Attachment - 83
`Attachment - 84
`
`Attachment - 85
`
`ztttachrnent : 86
`Attachment - 87
`
`Attachment - 88
`
`Attachment -. 89
`
`E
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`SERIAL NO:
`
`77/278969
`
`CORRESPONDENT ADDRESS:
`TRADEMARK DEPT.
`
`l\/IEDTRONIC, INC.
`710 MEDTRONTC PARKWAY
`LC 340
`MI
`APOLIS’ MN 554326604
`
`APPLICANT 1
`
`Mcdtronic, Inc.
`
`CORRE SPONDENT’S REFERENCE/DOCKET
`NO:
`
`Tl093US
`CORRESPONDENT E-MAIL ADDRESS:
`
`trademark@medtronic.com
`
`lllllllIlllllllllllllllllllllllllllIll
`
`GENERAL TRADEMARK INFORMATION:
`.
`-
`(1
`http.//www.uspt0.gov/mam/tra emarks.htm
`
`REQUEST FOR REC ONSIDERATION DENIED
`
`ISSUE/MAILING DATE: 2/19/2009
`
`Applicant is requesting reconsideration of a final refi1sa1 issued/mailed January 14, 2009.
`
`After careful consideration of the law and facts of the case, the examining attomey must deny the
`request for reconsideration and adhere to the final action as written since no new facts or reasons have
`been presented that are significant and compelling with regard to the point at issue.
`
`Applicant argues that the refusal based on a likelihood of confusion with the mark in U.S. Registration
`No. 2236135, CLOSURE, for intravascular catheters, should be withdrawn because the registrant
`“promotes its intravascular catheters for use in treating varicose veins.” App1icant’s mark is also
`CLOSURE and applicant’s goods consist of surgical implants and instrument sets for use in atrial
`occlusion procedures.
`
`A determination of whether there is a likelihood of confusion is made solely on the basis ofthe goods
`
`file://’ ‘xticrs-ais-O1\ticrsexport'\Htm1ToTifiInput\REC00012009_03~O4_l 1_02_10__'I'TAB08...
`
`3/4/2009
`
`

`
`TRADEMARK APPLICATION NO. 77278969 - CLOSURE - T1093US
`
`Page 4 of 4
`
`and/or services identified in the application and registration, without limitations or restrictions that are
`not reflected therein. In re Dakin '3 A/Iiniatures, Inc., 59 USPQ2d 1593, 1595 (TTAB 1999); TMEP
`§l207.0l(a)(iii). If the cited registration describes the goods and/or services broadly and there are no
`limitations as to their nature, type, charmels of trade or classes of purchasers, then it is presumed that the
`registration encompasses all goods and/or services of the type described, that they move in all normal
`chaxmels of trade, and that they are available to all potential customers. In re Linkvest S.A., 24 USPQ2d
`1716, 1716 (TTAB 1992); In re Elbaum, 211 USPQ 639, 640 (TTAB 1981); TMEP §1207.01(a)(iii).
`
`Here, no such limitations exist in the registration, which describes registrant’s goods broadly as,
`“intravascular catheters.” Thus, the registrant’s goods include goods that may be used for procedures
`similar to those for which the applicant’s goods are used. This is true even though the registrant’s goods
`may not yet be used for such procedures.
`
`Applicant further argues that the word “closure” is not descriptive of applicant’s goods. However, as the
`attached Intemet and article evidence suggests, the word “closure” is used in the medical field to refer to
`the occlusion of “atrial appendages” or areas within the heart during open heart surgery. See the
`attached definition found in Exhibit “Closure0-1” and the attached Intemet evidence, including Exhibit
`“Closure G1-01.” The word “closure” in this context thus describes the purpose, function or use of
`applicant’s surgical implants and instrument sets for use in atrial occlusion procedures.
`
`Accordingly, applicant’s request for reconsideration is denied. The time for appeal runs from the date
`the final action was issued/mailed. 37 C.F.R. Section 2.64(b); TMEP Section 7l5.03(c). If applicant
`has already filed a timely notice of appeal, the application will be forwarded to the Trademark Trial and
`Appeal Board (TTAB).
`
`/‘Edward Fennessy/
`Trademark Examining Attorney
`Law Office 114
`1.571.272.8804
`
`STATUS CHECK: Check the status of the application at least once every six months from the initial
`filing date using the USPTO Trademark Applications and Registrations Retrieval (TARR) online system
`at http://tarr.uspto.gov. When conducting an online status check, print and maintain a copy ofthe
`complete TARR screen. Ifthe status of your application has not changed for more than six months,
`please contact the assigned examining attorney.
`
`file://\\ticrs-ais-01\tiersexport\HtmlToTifi'Input\REC00Ol2009_03_O4_1 l_O2_10_TTABO 8...
`
`3/4/2009
`
`

`
`
`
`
`
`. ‘ ' ''htt 1//www.bio|o 02/19/200911:34Z38AM
`
`
`
`
`
`
`
`
`
` ,‘
`
`Join for Free!
`
`Heme
`
`Famm
`
`
`
`fimécses
`
`Tutoriais
`
`Saaks
`
`fi§i'e€:t::>I’y
`
`5i1esre3z'e:s:"wer$<
`
` :1 :t::v‘3:- :5: e wae
`
`
`
`‘M’ Atrial
`
`(S-mence‘ anazomy} Pertamnng to an atrmm.
`
`
`
`ti £.2:11§§&.: xs_‘”WQ§1_u;tiqz3
`Ccmm-acial Production and Editing
`Request an Estimate Today!
`mc‘i«.-centev zmwiaec
`
` ze .=‘«':>o'Jtm?hus Potantzslly
`Danger!) 3 H-f—an £‘—:rhythmIa. Free’
`bwa .:?s‘--,He,>:a’<=:‘.s.>a‘ea§t*--'-«I265 xv
`
`A V E]
`
`Mm 3
`
`I
`
`mI_r«_t@@
`
`Bse:o«,~Vs;:*.Ig;::
`
`Please conznbute to mas prcgect at vcu have mere infsrrrusmn abeutthas term feel free to
`
`
`
`een accessed 1,019 times.
`,4
`
`
`
`Solutinns
`
`Forums, News &
`
`Jobs Fantastic Pflzes
`far Scientists
`
`mm 5c:'e.'nm5<:lmi:-r4 gm
`
`sclsmznc Axfiaican Pzmmr Pinrwvrk
`1
`;
`“
`’
`*
`‘ | j.‘ ’~’
`'
`'
`"
`3
`@BioIogy—0nEine.crg.A1lRights Reserved. .'>'Qr=r
`
`Chemistry =f'f‘g — L!niversit,' Direcxo V. V
`Science Newark —
`an
`
`
`
`
`
`,5
`g .,
`'
`QBWKMRRK '! L 7”’
`
`’
`
`

`
`httg://www.biology—online.org/dictionam/Atrlum
`
`02/19/2009 11:35:07 AM
`
`
`‘
` r ’ ;
`Oflllne
`Join for Free}
`
`HOME
`
`Forum
`
`
`£3 Search
`
`fizrzicleé.
`
`lmoréais
`
`Beaks
`
`airecicry
`
`Snare wast wcrfx
`
`E A V
`AmbyGoogl¢
`Atrium
`_lgl_I_alt Diane
`lr:t_z=_.r_rx__§§_3jg
`Magic. Experience Paid
`lnternshép. Truly a—cne--of- Mfium
`a kind experiencer
`W,‘ ;,,,,e:,»,_3c_C,,,,,
`isclencez an:-1:*orny;a chamber used an anammlcal namenclature ta deslgnate 3 chamber aflardsng entrance to
`another sir séure or organ Llsually used alone to designate an alrium cfine hean.
`
`czsglnz L , gr. Alnon : hall Any chamberthat as corzneclea‘ to other xthambers orpassageways (especlally one cvllhe
`two uggeg chambers oflhe hear The central area ln 3 bullmng open ta the SIG A cnamberfounc an the heamhal
`receives de»3z;gen2?ed bleed lrum the bad;
`
`
`
`Eml
`
`{Pal}-.1 hlslory Pmiez la »ers~~>n
`A63 :1 Gccgle
`
`§c:§entist S_ _lu‘t'gQ§
`
`Forums, News 8. Jobs Fantastlc Prizes
`for Sciermsts
`
`W‘v‘1‘~\' sclentlsts;a§uuons.com
`
`£3¢®’1‘—3%1§C3i9—@i
`Cardscvascular meckcal
`devices and
`biexechnologias
`mwr zmumrveed rr/‘.1
`
` __
`0;*_3*;_¥‘ree
`M ans have already
`taken thés amazing test
`Whafs your RealAge'?'
`:ealA«ge iom
`
`.l\_II_i.u_ln
`Find and Request
`lnfarmat-ion from Atnum
`Assisted Lrvnngl
`m\w.Eld&rLi~zir>gSawae uzwr
`
`ljarrisburg University
`8 S. 8. MS, Gegree
`Programs Scfiech Fields.
`Financial Aid
`Now ’-ian§:.:y..:§L.> net
`
` @
`
`
`
`Please contribute to thzs prcgecl. lfyou have mere lnfcrmatzon ancutthrs term feelfree to
`
`This page was last modified 21:16, 3 Gclober 2005 This page has been accessed 2,173 tlmes.
`,._ '2"! ll“?
`
`
`2:3: Ml/gs
`1 59‘ "4
`n,...«9__;:] pg»
`
`l
`
`5clF.n"rl§-'29 AEKERICAN P212/that uetworx
`
`<5; Biolog)’—On€ine.e:g. All Rlghis Reserved. 8
`3.-
`2- Ufi'f~e'8f.’-liTy' Dlrecbzzrv l_
`Science Network »
`
`6 BUOKMRRK J‘ 2'} -“r-
`
`

`
`htt
`
`://www.bio|o
`
`02/19/2009 11:36:30 AM
`
`
`hifilogy orpline
`
`Join for Frse!
`
`Home
`
`Forum
`
`
`£3 Search
`
`Arziaées
`
`Tuzoriais
`
`Bucks
`
`Direzfizzsrgz
`
`Shaw yaurwork
`
`2% xcvaq ska wax
`
` -'78 I Page hzfiidf,/§Ffl=‘i.}iI6\i*fSX'1'S‘
`an :3.la
`
`Mfium
` ence: ansiomy; a chamber. used an arieiomicai nomeridafure ts desagnate a chamber efiordang enzrance»
`
`new strucéure or -argan. Usuairy useu aione to aesigraate anauium cf the need
`O:sgin- ,g;.A1ri~.>n = h3H."-,mCh3f(lbE}T1hah5 connefled to vstirier chambers or passageways (>33;>BC!ai§_~‘ one c-Hhe
`Mo ugg-er chambers oitne heart: The centra! area in a fiuiiding ogen Is the sky A cnemnerfounci an the hearzthat
`re<:-we: deox:.gen3?ed bland mm the body.
`
`'
`
`'
`
`'
`
`Forums, News & Jobs Fantastic Prizes
`for SUEHUSIS
`
`www scientistsg§_utior:s.com
`
` ya .TI;E-__.
`
` g: Hay
`
`
`
`Please ccnmbute to this prcgect ifyou have more infcrmahon a?3=3Lnt‘rizs term feel free to
`
`This page was Sast modified 21.16, 3 C one: 2005 This as e has been accessed 2.173 times.
`
`"
`5 ‘~95?
`"“
`"
`
`Adsbyfiooglc
`
`EAV
`
` W_=’2!£Pé_i@¥.Lf1L%m.§hi£2
`
`Magic Experience. Paid
`Internship. Truly a—an9~o€~
`a kind experience.
`W-Ear Dissey Gamma
`
`
`
`biolechnologies
`wawy. 23: com
`
`
`
`0;:‘_:»J;x's:c:_T;<:_§1
`I‘!
`M ions have already
`taiargn (ms amazing test.
`‘v’-fhat's your RealAge?
`§t_%f1|r".>9€
`:<:~u
`
`pgigm
`Find and Request
`Information from Atzium
`Assasted Living!
`#95’?! EiaerLi»/iragsautse a:.z:-*3“
`
`iieggzjsbuyg i}i1iv_§i_’;3jgy
`E53. 8. M S. Qegree
`Pragrarrss Sci':’ech =’-"welds
`Financial Aid
`.ww« -ianiscutgu. -‘vet
`
`Q BOOKPRRK Q? 9.} 3‘? _
`
`
`
` « Chemistry] ~
`
`SCIEMTQFSC AMERECAN Pzsrmcr Hamurk
`
`Biolr.-gyv0nEine.o: All Rights Resewed.T;?m§i<‘xc_r1i_.*»'
`Science Network
`§-L§.'?HE'(3iTyDi:'eC1v./ :3]
`
`
`

`
`h@://wwwlexis.com/research/retrieve’? m=8a9050bb823df6942fa988129d3c19ac&docnum=1& fmtstr=FULL& star1doc=1&w
`chg=dGLbVzz—zSkAz& md5=a4408282d02b4ce401e9ac9d36d5657a&focBudTerm5=atrial%20and%20irnglant%20and%20catheter&fo
`
`cel
`02//01:47:8
`'
`“‘»l*“.l ’\ i"r
`7'01.)-’ i\‘:‘u'.1rrh.S'vs!4*n7
`301'?“ Ole” F"-';“'?"'3"=j 1"‘FL‘ R;
`Hvztcr.
`
`
`
`
`
`FOCUS” Terms latrial and implant and i Search Within r“—_*“*“:_|on».,;..iMug (1 . my .
`
`Advanced...
`
`
`
`
`Professional 8‘ Practice Materials V (101) D
`View: % | KWIC 1 Full | Custom
`:1 of 101 a>
`Q re"
`More Like This | More Like Selecieg Text
`
`
`
`Source: Combined Source Set 106 13"-"Cardiovascular Week; Surgery Litigation & Law Weekly; Health 8 Medicine Wee...
`Terms: atrial and implant and catheter (Edit Search I Suggest Terms for My Search)
`
`‘Select for FOCUS” or Delivery
`F‘
`
`ATRIAL FIBRILLATION; VCU Pauley Heart Center First to use Technolcgically Enhanced Intracardiac Ultrasound for the Treatment
`of Atrial Fibrillation Surgery Litigation & Law Weekly January 9, 2009
`
`Copyright 2009 Surgery Litigation & Law Weekly via LawRx.com via NewsRx.com and NewsRx.net
`Surgery Litigation & Law Weekly
`
`January 9, 2009
`
`SECTION: EXPANDED REPORTING; Pg. 120
`
`LENGTH: 903 words
`
`HEADLINE: LEI. FIBRILLATION;
`VCU Pauley Heart Center First to use Technologically Enhanced Intracardiac Ultrasound for the Treatment of Atria! Fibrillation
`
`BODY:
`
`
`
`The Virginia Commonwealth University Pauley Heart Center is the first in the United States to use a new type of intracardiac
`
`gig»
`:,:
`«4
`:,i’;:
`''
`1;,
`14 Doc[““« ‘§.?o11o1
`>134 rerm|""1 ‘£0119
`
`
`
`
`_
`M
`
`

`
`htt
`
`://wwwlexis.com/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=1& fmtstr=FULL& startd0c=1&w
`
`ciEi3g=céGLbVzz—z8l<Az& md5=a4408282d02b4ce401e9ac9d36d5657a&focBudTerms=atria|%20and%20imgIant°/o20and%20catheter&fo
`c ud el=all
`
` 02/19/2009 11 147148 AM
`
`Results -
`
`Professional 8. Practice liiaterials » (101) >
`
`View: E l K\NlC l Full | Custom
`
`<31 of 101 5?’
`More Like Thi§ | More Like Selected Text
`
`:i§'?i’~ Q Q3’
`
`BODY:
`
`The Virginia Commonwealth University Pauley Heart Center is the first in the United States to use a new type of intracardiac
`ultrasound machine that produces enhanced imaging of the heart, allowing cardiac electrophysiologists to better diagnose and
`treat atrial fibrillation (see also Atrial Fibrillation).
`
`Atrial fibrillation, or a-fib, is caused by abnormal electrical impulses that begin at the top of the heart and travel down the upper
`chambers, or atria, causing erratic contractions. The irregular rhythm, which affects more than 2 million Americans, interferes
`with the heart's ability to efficiently pump blood. As a result, blood can pool in the atria, which can lead to the formation of clots
`and the possibility of a stroke.
`
`Intracardiac ultrasound (ICU) is a technique that allows doctors to better visualize structures in the heart using aspecial
`catheter that is laced through a blood vessel in the leg and advanced into the heart. Traditionaily, ultrasound imaging of the
`heart is done outside the chest with a probe and requires a large, heavy machine that cannot be moved easily.
`
`"Using the ICU catheter allows us to better visualize important structures in the heart, it allows us to better move our catheters
`around more safeiy inside the heart and finally, it allows us to move catheters to certain areas in the heart where we feel we
`need to deliver radio frequency energy so we can ablate the right tissues," said Kenneth Ellenbogen, M.D., professor of cardiology
`and director of the cardiac electrophysiology lab at the VCU Medical Center, who performed the imaging technique using the new
`technology.
`
`GE Healthcare .developed the small and compact, Vivid i system that delivers imaging performance equal to that of today's
`leading high—end console ultrasound systems without crowding the lab. The Vivid i ultrasound system displays high quality
`‘manmj./ynf the fizflfifnftjl/(Hi qtriirttiirns nf thpmhoartganrl deliratp valvular <:trurfurm: )l'i¢=lninn(l'n imnrnwa offi’/rgarv nf4/the catheter _
`M
`___,.=»
`_
`$53
`,
`«i/.1
`i
`'
`,
`M ~.
`,
`3'51’
`Aouflinf
`§?ac;+2 Selectaflepcrzer
`‘$9 ol101 M H Term]
`2 E? of 19
`,
`l
`Doc}
`1
`
`
`_.
`N
`
`

`
`://www.|exis.com/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=‘l& fmtstr=FULL& startdoc=1&w
`chg=dGLbVzz—zSW& md5=a4408282c|02b4ce401e9ac9d36d5657a&iocBudTerms=atria|%20and%20imglant°/o20and%20catheter&fo
`cBl=|
`02/19/2009 1‘I:8:1 AM
`
`l.M.:~“~.: »\:~.
`
`Professional & Practice Materials » (101) V
`
`Results -
`
`View: % 1 KWIC | Full 1 Custom
`
`,:1 of 101 :%=
`do e Like This I w1m
`
`. as Q {:5 a”
`
`Pages
`
`leading high-end console ultrasound systemswithbut crowding the lab. The Vivid lihulttiasound system displayrslhighl quality
`images of the anatomical structures of the heart and delicate valvular structures, helping to improve efficacy of the catheter
`ablation and patient safety.
`
`"We're going from a machine that is quite big and takes up a lot of space to one the size of a laptop computer that is positioned
`at the bedside. It gives us spectacular images of the heart, our catheters in the heart and the structures in the heart and helps
`us do an even better job of ablating atrial fibrillation more safely and more effectively," Elienbogen said.
`
`Using ICU, cardiac electrophysioiogists can to some extent avoid or decrease the use of X-ray or radiation to image the heart
`because the catheter uses sound waves to help detect what‘s going on in the heart.
`
`About 10 years ago, VCU cardiac electrophysiologists, together with experts from several other centers, pioneered the use of this
`catheter to treat a-fib.
`
`Catheter ablation is used to burn sites inside the atria and ventricles the heart's lower pumping chambers that cause
`arrhythmias. In the procedure, one or more catheters is piaced inside the heart to locate the origin of the electrical short
`circuits. Once the area is located, the surgeon delivers heat energy to destroy the abnormal electrical circuit.
`
`"Through catheter ablation of a-fib, our main goal is not just to improve efficacy but to make it safer for patients. The way we do
`that is to make it so we're better able to visualize what we're doing inside the heart, by avoiding delicate structures that we don't
`want to treat and using our imaging tools and technology to get the best and safest results,“ Ellenbogen said.
`
`##3%
`
`bout the VCU Paulev ljiearl‘ Center: The VCU Paulev Heart Center is,reconr1i7ed natinnallvfor its heart failure and heart
`, £333.
`
`v~ N ., w Q4 Boc[——1 E? OHO1 D: $4 rerm|"“2 Eliot 19
`
`
`
`
`
`Aoutlinei
`
`
`
`
`
`

`
`httg://www.Iexiscom/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=1& fmtstr=FULL& startdoc=1&w
`chg=dGLbVzz-zSkAz& md5=a4408282d02b4ce401e9ac9d36d5657a&focBudTenns=atrial%20and%20imgIant%20and%20catheter&fo
`cBSei=ai
`
`file’:-nr,=_'~_ _<i*nF,Li E
`Hl":"‘i
`
`02/19/209 11:48:1AM .:a..icn Client
`
`FOCUS” Terms lama‘ and lmplam 3"‘-l ' Search Within 1 Original Results (1 - 10::-«as I
`
`Advanced...
`
`Results ~ (10_l')_\ Professional 8. Practice Materials - (101) >
`
`View m | KWiC 1 Full 1 Custom
`
`:3 1 of 101 :>
`More Lire This | More Like Selected Text
`
`El 3:7; in“
`
`###
`
`About the VCU Pauley Heart Center: The VCU Pauley Heart Center is recognized nationally for its heart failure and heart
`transplantation programs, and was among the first in the United States to implant the Cardiowest temporary Total Artificial
`Heart, or TAH-t the only total artificial heart approved by the U.S. Food and Drug Administration. The heart center is comprised of
`the Divisions of Cardiology, Cardiothoracic Surgery and Pediatric Cardiology. There is close collaboration between the divisions to
`provide advanced, patient-centered care to patients of all ages, with every type of heart disease, with the best possible
`outcomes. Pauley Heart Center's superior performance resulted in VCU Medical Center being recognized as one of the top 100
`U.S. hospitals for cardiovascular care, according to a Thomson Reuters study.
`
`About VCU and the VCU Medical Center: Virginia Commonwealth University is the largest university in Virginia and ranks among
`the top 100 universities in the country in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls
`32,000 students in 205 certificate and degree programs in the arts, sciences and humanities. Sixty—five of the programs are
`unique in Virginia, many of them crossing the disciplines of VCU's 15 schools and one coilege. MCV Hospitals and the health
`sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic
`medical centers. For more, see www.vcu.edu.
`
`CONTACT: Joe Kuttenkuler
`
`VCU Communications and Public Reiations
`
`Phone: 804.827.6607
`kw
`*__ it
`Aouiiinel
`
`~t:;;:
`
`» .,
`
`.£.w
`
`.
`
`M
`
`515:;
`
`:41,‘
`lfiatze Selsctafilegzsrzar
`
`»
`
`
`ll
`‘:33? W
`,,::;,
`11:”
`[4 Doc [-7 '39 oi'l01 M ;4 rem [*2 ‘:3 ol19
`
`’
`
`bl
`
`

`
`://wwwlexis.com/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=4& fmtstr=FULL& startdoc=1&w
`htt
`chg=dGLbVzz—zSkAz& md5=a4408282d02b4ce401e9ac9d38d5657a&focBudTerms=atria|%20and%20imglant%20and%20catheter&f0
`ul=all
`02/19/209 1115010 AM
`ll
`‘‘
`'.
`Tum/‘ l\'«wr.lIrh.\“ysrnn1
`
`'
`
`
`
`FOCUS” Terms laifial and implant and‘ Search Within [Original Ruulu (x - 101:» ..~ I W Advanced___
`
`~ (10'l):\( Professional & Practice Materials » £101} v
`
`View: §_it_e| KWICI Full | Custom
`
`Q 4 of 101 :9
`More Like This | More Like Selected Text
`
`Source: Combined Source Set 105 Q - Cardiovascular Week; Siargery Litigation 8. Law Weekly; ‘Health & Medicine Wee;
`Terms: atrial and implant and catheter (Edit Search l Suggest Terms for My Search)
`‘
`
`wrselect for FOCUS 7"‘ or Delivery
`I"
`
`ST. JUDE MEDICAL, INC. ; St. Jude Medical Announces the Release of Ensite System Version 8.0 Software Cardiovascular Week
`May 26, 2008
`
`Copyright 2008 Cardiovascular Week via NewsRx.com & NewsRx.net
`Cardiovascular Week
`
`May 26, 2008
`
`SECTION: EXPANDED REPORTING; Pg. 566
`
`LENGTH: 594 words
`
`HEADLINE: §T. JUDE MEDICAL. INC ..;
`St. Jude Medical
`.Announces the Release of EnSite System Version 8.0 Software
`
`BODY:
`
`St.‘ Jude Medical, Inc .. (NYSE:ST1 .) announced the releaee of its EnSi_te(TM) System Version 8.Q eoftware. Theynew software will
`« am '
`mm’ '
`>» mm
`~.&.<’
`;
`*5”
`'
`» m____
`~ "
`.
`V’
`y
`:2’
`;.;’,1
`
`r A Outline
`‘$3019
`l4‘j9ol1O1 Dlflferml
`
`gm.
`3%
`
`

`
`':l("."lr_1i
`H??l?l’
`
`1//www.Iexis.corn/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=4& fmtstr=FULL& startdoc=1&w
`chg=dGLbVzz-z8kAz& md5=a4408282d02b4ce401e9ac9d36d5657a&focBudTerrns=atriaI%20and%20img|ant%20and%20catheter&fo
`cBul
`0/19/2009 11:51:02
`
`
`
`:.3.i':l7 C_iiE_ig F‘iE'-3;¢_l1C‘E"j
`
`Professional 8. Practice Materials - (101) I
`
`View: _Qlt_e I KVVIC l Full I Custom
`
`xi 4 of 101 $9
`MOFE Like This | More Like Selected Text
`
`:i§.‘sl"v B (9:93 ‘€-
`
`Pages
`
`its EnSite(TMl System Version 8.0 software. The new software will
`St. Jude Medical, inc -. (lNYSE:STJ .) announced the release
`help physicians more intuitively visualize the anatomy of the heart to diagnose and treat abnormal heart rhythms.
`St. Jude Medical
`.will feature the Ensite v.8.0 at Heart Rhythm 2008 on May 14 - 17 (see also St. Jude Medical, Inc.).
`
`The Ensite System is used in minimally invasive electrophysiology (EP) procedures. Catheters with electrodes are inserted into
`the cardiac chamber and then are located and visualized by the Ensite System, which records electrical information and creates a
`rendering of the chamber anatomy. The resulting images help physicians create detailed heart models to facilitate the diagnosis
`and delivery of therapy for abnormal atrial heart rhythms, including Atrial Fibrillation (AF). The Ensite System allows catheter
`navigation to occur without fluoroscopy and reduces the risk associated with too much exposure to X-rays.
`
`The new Ensite v.8.0 software expands the capability of the Ensite System to help physicians better visualize reentrant
`arrhythmia circuits, a common abnormal heart rhythm. The Ensite v.8.0 also gives physicians the ability to view how these
`reentrant circuits propagate or move about the cardiac chamber. This feature improves physicians‘ ability to identify the location
`of the arrhythmia so they have more control over the procedure.
`
`Additional features include map visualization enhancements, which provide a more realistic perspective on the location of
`catheters, lesions, and anatomical points of interest. EnSite v.8.0 also includes enhancements to the electrical "noise" filters to
`improve cardiac signal detection and heip physicians better analyze low amplitude signals such as complex fractionated
`electrograms, a growing area of interest for EP physicians.
`
`"This new version of our Ensite System will help physicians better diagnose their patients with arrhythmias," said Jane J. Song,
`president of the St. Jude Medical
`.Atrial Fibrillation Division. "It also underscores our leadership in the industry and our
`continued dedication to improving the lives of patients."
`Qnrl‘
`
`bvlthrvl ?,nns2
`
`V
`
`Fallon V1‘?-IQO Maw 14.17 :1? l-he Mnprnno fffnnuont-,inn Ponifor in Can Frnngricrn The VYVOOQ/,‘il"\(| ic 1'ho»rnnc’i-
`M .
`...r.,»,
`W
`3%,.
`ma“,
`Wm
`W.
`W5,
`_:w,,,,
`my.
`-».» i
`am
`saw
`new
`.4». 2
`~~,_,
`wax».
`~
`. am.
`\:>.
`~
`\
` l R308 S-elect: Fsggsrzar
`g4 re:m|"“"3¥oi9
`2:4 Doc
`bi
`
`4 3901101
`
`7...
`>;
`
`

`
`t//wwwlexls.com/research/retneve’? m=8a9050bb823df6942fa988‘l29d3c19ac&d0cnum=4& fmtstr=FULL& startdoc=1&w
`chg=dGLbVzz-zSkAz& md5=a4408282d02b4ce401e9ac9d36d5657a&focBudTen'ns=atrial%20and%20img|ant%20and%20catheter&fo
`uSI=aII _
`_
`
`7 0/19/2009 11::42 AM
`
`
`
`FOCUS” Terms atrial and implant and ' Search Within [Taniamt. (2 . 1a1j-‘iv.
`
`Advanced...
`
`Professional 8. Practice materials 7 (101) >
`
`View: gig] KWlCl Full 1 Custom
`
`«ii 4 of 101 3:}
`More Like This | More Like Selected e2r_l
`
`:i'§.”s'i".
`
`[#3] 93'.
`
`Heart Rhythm 2008 takes place May 14-17 at the Moscone Convention Center in San Francisco. The meeting is the most
`comprehensive educational event on heart rhythm disorders, offering 250 educational opportunities in multiple formats. The
`world's most renowned scientists and physicians will present a wide range of heart rhythm topics including advances in statins,
`cardiac resynchronization therapy, catheter ablation, cardiac pacing and heart failure and the latest technology, including state-
`of-the-art pacemakers and defibrillators. www.HRSonline.org
`
`St. Jude Medical -Highlights at Heart Rhythm 2008
`
`On Thursday, May 15 at 1:30 p.m., during the oral abstract session, Andrew Epstein, M.D., will present the results of multiple
`St. Jude Medical
`.lead registries. The studies analyzed the experience of more than 7,000 patients who were implanted with
`Riata high voltage leads. In addition, St. Jude Medical
`.wiil showcase new cardiac leads and cardiac iead implant tools, new
`electronic health record connectivity features and the company's cardiac rhythm management device programmer (which is now
`available in eight languages).
`
`Keywords: Anatomy, Arrhythmia, Atrial Fibrillation, Cardiology, Electrophysiology, Physiology, Therapy, Treatment,
`St. Jude Medical Inc. .
`
`This article was prepared by Cardiovascular Week editors from staff and other reports. Copyright 2008, Cardiovascuiar Week via
`lglewsfixcom.
`
`LOAD-DATE: May 21, 2008
`
`H
`
`finiirce; Combined Source Set 105
`, W.
`,,,,,~.
`\
`..
`.\
`\{
`~
`'
`Aoutline
`
`.
`
`>smcA<'
`'
`- Cardiovascular Week: Suraerv Litiaation 8. Law Weekly: Health & Medicine Wee...
`,,.
`.
`,3 i
`,
`0
`..
`,
`
`ligflifire Seieczalleacztev
`
`
`
`I
`
`i‘ DOC!
`
`-4 3? 03101 ”
`
`Tenn]
`
`
`
`A
`K
`(3? 0' 9
`
`

`
`:1/www.Iexiscom/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=7& fmtstr=FULL& startdoc=1&w
`htt
`chg=dGLbVzz-zSkAz& md5=a4408282d02b4ce401e9ac9d36d5657a&focBudTerm5=atrial%20and%20img|ant%20and%20catheter&fo
`cBudSel=a|| ? 02/19/2009 11:53:47 AM
`
` FOCUS” Terms latrial and implant and < Search Within Original Results (3 - mxj % Advanced...
`Results -(1053 - Professional & Practice Materials - £101‘: >
`
`Vlewl 91:2 1 KWlC] Fun 1 Custom
`
`«; 7 of 101 2:9
`More Like This [More Like Selected Text
`
`El
`
`w” »
`
`- Cardiovascular Week; "Sui'gei'f titigaiion 8".‘ Lafii Weekljfi "Health 8. Medicine >V'llee..;'
`‘So(§ce:" Coniltuiined Sou1‘rt:e‘S‘etm106€f
`Terms: atrial and implant and catheter (Edit Search | Suggest Terms for My Search)
`
`{Select for FOCUS W‘ or Delivezy
`I"
`
`BIOMEDICINE; Aporo Biomedical Announces Global Licensing Agreement for Proprietary Polymers Used to Treat Structural Heart
`Disease Cardiovascular Week February 1 1, 2008
`
`Copyright 2008 Cardiovascular Week via NewsRx.com & NewsRx.net
`Cardiovascular Week
`
`February 11, 2008
`
`SECTION: EXPANDED REPORTING; Pg. 407
`
`LENGTH: 550 words
`
`HEADLINE: BIOMEDICINE;
`Aporo Biomedical Announces Globai Licensing Agreement for Proprietary Polymers Used to Treat Structural Heart Disease
`
`BODY:
`
`Aporo Biomedical, a San Francisco/Bay Area—based medical device company, reported an exclusive global licensing agreement
`
`
`
`
`
`
`ll fees :2
`
` let: a Regzayzer
`
`
`
`
`
`“£076
`
`diq i)ocfl§“—'1 39 $01 >
`W
`
`
`
`Texas]
`
`

`
`
`
`://www.lexis.com/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=7& fmtstr=FULL& startdoc=1&w
`chg=dGLbVzz-zSl<Az& md5=a4408282d02b4ce401e9ac9d36d6657a&focBudTerms=atria|%20and%20imglant%20and%20catheter&fo
`cBudSe|=a||
`19/2009 1155225 AM
`'
`
`
`
`Smith Cheri Preferences ‘Eran Gui ii
`Histm
`
`Professional & Practice lilaterials < £101) >
`
`View: % l KWICI Full [ Custom
`
`<35 7 of 101 $
`More Like This I More Like Selected Text
`
`Q V. .
`
`Pages
`
`Aporo Biomedical, a San Francisco/Bay Area—based medical device company, reported an exclusive global licensing agreement
`with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP(TM)). Aporo's goal is to provide
`significant clinical value by delivering novel transcatheter devices that close defects and then biodegrade over time, leaving
`behind no permanent implant. Initially, Aporo will use these materials to treat Patent Foramen Ovale (PFC), a type of structural
`heart disease that involves closing an open tunnel between the upper left and right chambers of the heart. In the future, the
`company will use the ol mers in devices to treat Atrial Septal Defect (ASD), another structural heart disease, and for vascular
`
`closure after atheter—based interventional roceciures (see also Biomedicine).
`
`While a PFO typically closes within the First few days alter birth, approximately 25% of the population has a passageway or hole
`that remains open. In fact, PFO‘s may cause an estimated 200,000 strokes per year. PFO‘s are also believed to he a factor in
`migraine headaches, which affect 12% of the population. Studies indicate that PFO closure may bring migraine relief. Currently,
`several transcatheter closure devices are in clinical trials to evaluate PFC closure and the impact on stroke and migraine.
`
`Although minimally invasive catheter-based procedures are relatively short and can provide significant benefits to the patient,
`there is a growing desire among clinicians to avoid the potential complications and disadvantages from permanently implanting a
`large device in an otherwise healthy heart. Aporo Biomedical will address this concern by delivering a biodegradable device that
`closes the PFO without leaving a permanent implant.
`
`“The next significant advance in medical technology will be biodegradable devices that disappear once they've done their job,"
`commented Carolyn Patrick, President and CEO of Aporo Biomedical. "As patients are treated younger and live longer, it's even
`more important for physicians to have options that consider not only the patients‘ immediate outcomes and quality of life, but
`their future medical needs as well. Aporo Biomedical is well—positioned to advance the field of PFO closure with a fully
`biodegradable device. We look forward to working with mNEMOSCIENCE(R) and utilizing the novel BIO-SMP(TlVl) technology to
`bring these transformative devices to market."
`
`
`Aoutline
`If
`bi
`‘
`'
`A:
`l
`‘l
`lfiage seiaeaeessrxs:
`1; H DoCVl‘"7‘3‘-‘)olA'i01
`Vi
`
`Term]
`
`.2 “.9016
`
`H
`
`v «//«ms
`
`er
`
`3%/“
`
`t”
`
`

`
`://www.Iexisicom/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=7& fmtstr=FULL& startdoc=1&w
` htt
`cl1g_=_dGLbVzz-zSkAz& md5=a4408282d02b4ce401e9ac9d36d5657a&focBudTem1s=atna|%20and%20irnQ|ant°/o20and%20catheter&fo
`
`Results —(101)'\ Professional 8. Practice lllaterials - (101) V
`
`view: % | KWIC 1 Full | Custom
`
`«is 7 or 101 e
`More Like This more Like Selected Text
`
`Dl'll"lg ‘CD952 transrormative CIEVICES [0 market."
`
`E]
`
`as”
`
`Pages
`
`"We are delighted to partner with such a skilled and innovative medical device manufacturer for our BIO—SMP(TM) technology,"
`said Christian Palme, CEO, mNEMOSCIENCE. "Securing high—quality, progressive partners like Aporo Biomedical has been a key
`focus of our strategic development plan and represents an important milestone in advancing our BIO-SMP(TM) commerciaiization
`program."
`
`Terms of the agreement were not disclosed.
`
`Keywords: Atrial Septal Defect, Bioengineering, Biomedical Engineering, Biomedicine, Business, Cardiology, Clinical Trial
`Research, Headache, Heart Disease, Marketing and Licensing Agreements, Medical Device, Migraine, Migraine Disorder,
`Neuroiogy, Patent Actions, Patents, Aporo Biomedical.
`
`This article was prepared by Cardiovascular Week editors from staff and other reports. Copyright 2008, Cardiovascular Week via
`New§Rx.com_.
`
`LOAD-DATE: February 8, 2008
`
`- Cardiovascular Week; Surgery Litigation & Law Weekly; Health 8. Medicine Wee...
`Source: Combined Source Set106
`Terms: atrial and knplan! and catheter (Edit Search 1 Suggest Terms for My Search)
`View: Full
`Date/Tme: Thursday, February 19, 2009 - 11:52 AM EST
`
`.
`pg
`
`>134 rermracaoia
`
`94 ooc|—7'<:.9ouo1
`
`

`
`://www.Iexiscom/research/retrieve? m=8a9050bb823df6942fa988129d3c19ac&docnum=9& fmtstr=